ATE187166T1 - N-(dihydroxyalkyl)-ethinylalanin-amide mit endständiger azacyclyl-gruppe für die behandlung von bluthochdruck - Google Patents

N-(dihydroxyalkyl)-ethinylalanin-amide mit endständiger azacyclyl-gruppe für die behandlung von bluthochdruck

Info

Publication number: ATE187166T1
Authority: AT; Austria
Prior art keywords: hypertension; treatment; hydrido; terminated; ethinylalanine
Prior art date: 1992-08-14

Application number

AT93906079T

Other languages

English (en)

Inventor

Gunnar J Hanson

Original Assignee

Searle & Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-08-14

Filing date

1993-02-24

Publication date

1999-12-15

1993-02-24 Application filed by Searle & Co filed Critical Searle & Co

1999-12-15 Application granted granted Critical

1999-12-15 Publication of ATE187166T1 publication Critical patent/ATE187166T1/de

Links

206010020772 Hypertension Diseases 0.000 title abstract 2
150000001408 amides Chemical class 0.000 title 1
-1 alkylamino ethynyl alanine amino diol Chemical class 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
125000001145 hydrido group Chemical group *[H] 0.000 abstract 2
239000000126 substance Substances 0.000 abstract 2
125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 1
125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 abstract 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 abstract 1
125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 abstract 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
125000004430 oxygen atom Chemical group O* 0.000 abstract 1
125000003386 piperidinyl group Chemical group 0.000 abstract 1
239000002461 renin inhibitor Substances 0.000 abstract 1
229940086526 renin-inhibitors Drugs 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/38—Halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Peptides Or Proteins (AREA)
Indole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Cephalosporin Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT93906079T 1992-08-14 1993-02-24 N-(dihydroxyalkyl)-ethinylalanin-amide mit endständiger azacyclyl-gruppe für die behandlung von bluthochdruck ATE187166T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/930,061 US5212185A (en)	1992-08-14	1992-08-14	Piperidinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension

Publications (1)

Publication Number	Publication Date
ATE187166T1 true ATE187166T1 (de)	1999-12-15

Family

ID=25458874

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93906079T ATE187166T1 (de)	1992-08-14	1993-02-24	N-(dihydroxyalkyl)-ethinylalanin-amide mit endständiger azacyclyl-gruppe für die behandlung von bluthochdruck

Country Status (12)

Country	Link
US (3)	US5212185A (de)
EP (1)	EP0655056B1 (de)
JP (1)	JP3363448B2 (de)
AT (1)	ATE187166T1 (de)
AU (1)	AU3725393A (de)
CA (1)	CA2136836C (de)
DE (1)	DE69327166T2 (de)
DK (1)	DK0655056T3 (de)
ES (1)	ES2141148T3 (de)
GR (1)	GR3032526T3 (de)
PT (1)	PT655056E (de)
WO (1)	WO1994004495A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2143993T3 (es) *	1991-12-11	2000-06-01	Yoshitomi Pharmaceutical	Farmaco para tratar una enfermedad autoinmune.
US5422349A (en) *	1992-08-14	1995-06-06	G. D. Seale & Co.	Morpholino-oxazinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
US5508466A (en) *	1994-04-13	1996-04-16	G.D. Searle & Co.	Synthesis of N-protected-α-substituted-glycine racemic esters by zinc-mediated addition of organic halide to glycine cation equivalent
JP4524015B2 (ja) *	1999-11-17	2010-08-11	キッセイ薬品工業株式会社	（２ｓ）−２−ベンジルコハク酸モノエステルの有機アミン塩およびその製造方法
US7425537B2 (en)	2000-08-22	2008-09-16	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	SH2 domain binding inhibitors
CA2467476A1 (en) *	2001-11-19	2003-05-30	Pharmacia & Upjohn Company	Amino diols useful in the treatment of alzheimer's disease
AU2005274927B2 (en)	2004-07-15	2011-11-03	Albany Molecular Research, Inc.	Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
US9156812B2 (en)	2008-06-04	2015-10-13	Bristol-Myers Squibb Company	Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
US8802696B2 (en) *	2009-05-12	2014-08-12	Albany Molecular Research, Inc.	7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoqu inoli and use thereof
WO2010132487A1 (en)	2009-05-12	2010-11-18	Bristol-Myers Squibb Company	CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
CN102458123A (zh) *	2009-05-12	2012-05-16	阿尔巴尼分子研究公司	芳基、杂芳基和杂环取代的四氢异喹啉及其用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3006913A (en) *	1959-06-10	1961-10-31	Ciba Pharm Prod Inc	Process for preparing (n,n-alkylene-imino)-lower alkyl-guanidines
US3236836A (en) *	1963-07-17	1966-02-22	Searle & Co	3-substituted 1-(3-azabicyclo[3.2.2]non-3-yl) alkyl-2-thioureas
JPS59227851A (ja) *	1983-06-09	1984-12-21	Sankyo Co Ltd	レニン阻害作用を有するペプチド類
EP0181110A3 (de) *	1984-10-22	1988-05-11	Kissei Pharmaceutical Co. Ltd.	Histidinderivate als Renininhibitoren
SU1676454A3 (ru) *	1984-11-30	1991-09-07	Санкио Компани Лимитед (Фирма)	Способ получени пептидов или их фармацевтически приемлемых солей
DK34086A (da) *	1985-01-23	1986-07-24	Abbott Lab	Peptidylaminodioler
JPS61236770A (ja) *	1985-04-15	1986-10-22	Kissei Pharmaceut Co Ltd	新規なアミノ酸誘導体
JPS6256458A (ja) *	1985-09-04	1987-03-12	Kissei Pharmaceut Co Ltd	新規なアミノ酸誘導体
JPS63503380A (ja) *	1986-01-16	1988-12-08	アボット・ラボラトリーズ	ペプチド類似体
IL81234A (en) *	1986-01-16	1992-09-06	Abbott Lab	Peptidylaminodiols,process for their preparation and pharmaceutical compositions comprising them
US4895834A (en) *	1986-12-15	1990-01-23	Warner-Lambert Company	Renin inhibitors III
US5032577A (en) *	1986-12-31	1991-07-16	Abbott Laboratories	Peptidylaminodiols
US4921855A (en) *	1987-06-22	1990-05-01	Fujisawa Pharmaceutical Co., Ltd.	New Histidyl amino acid derivatives, and pharmaceutical composition comprising the same
US5089471A (en) *	1987-10-01	1992-02-18	G. D. Searle & Co.	Peptidyl beta-aminoacyl aminodiol carbamates as anti-hypertensive agents
CA1328333C (en) *	1988-03-04	1994-04-05	Quirico Branca	Amino acid derivatives
US4902706A (en) *	1988-07-01	1990-02-20	G. D. Searle & Co.	Aminoalkylaminocarbonyl aminodiol amino acid derivatives as antihypertensive agents
AU615313B2 (en) *	1988-07-01	1991-09-26	G.D. Searle & Co.	Aminoalkylaminocarbonyl aminodiol amino acid derivatives as anti-hypertensive agents
US5164388A (en) *	1988-10-19	1992-11-17	Abbott Laboratories	Heterocyclic peptide renin inhibitors
IE902446A1 (en) *	1989-07-26	1991-02-13	Abbott Lab	Peptidyl aminodiol renin inhibitors
CA2023099A1 (en) *	1989-09-04	1991-03-05	Quirico Branca	Amino acid derivatives
NZ235234A (en) *	1989-09-12	1992-12-23	Hoechst Ag	Renin-inhibiting amino acid derivatives and pharmaceutical compositions thereof
US5098924A (en) *	1989-09-15	1992-03-24	E. R. Squibb & Sons, Inc.	Diol sulfonamide and sulfinyl renin inhibitors
TW209870B (de) *	1990-01-18	1993-07-21	Pfizer
IE68045B1 (en) *	1990-05-11	1996-05-15	Abbott Lab	Renin inhibitors

1992
- 1992-08-14 US US07/930,061 patent/US5212185A/en not_active Expired - Lifetime
1993
- 1993-02-24 EP EP93906079A patent/EP0655056B1/de not_active Expired - Lifetime
- 1993-02-24 AU AU37253/93A patent/AU3725393A/en not_active Abandoned
- 1993-02-24 WO PCT/US1993/001479 patent/WO1994004495A1/en not_active Ceased
- 1993-02-24 AT AT93906079T patent/ATE187166T1/de not_active IP Right Cessation
- 1993-02-24 DE DE69327166T patent/DE69327166T2/de not_active Expired - Fee Related
- 1993-02-24 PT PT93906079T patent/PT655056E/pt unknown
- 1993-02-24 JP JP50622194A patent/JP3363448B2/ja not_active Expired - Fee Related
- 1993-02-24 ES ES93906079T patent/ES2141148T3/es not_active Expired - Lifetime
- 1993-02-24 DK DK93906079T patent/DK0655056T3/da active
- 1993-02-24 CA CA002136836A patent/CA2136836C/en not_active Expired - Fee Related
- 1993-04-16 US US08/048,623 patent/US5304552A/en not_active Expired - Fee Related
1994
- 1994-03-14 US US08/212,088 patent/US5385898A/en not_active Expired - Fee Related
2000
- 2000-01-31 GR GR20000400222T patent/GR3032526T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
ES2141148T3 (es)	2000-03-16
US5385898A (en)	1995-01-31
EP0655056B1 (de)	1999-12-01
US5304552A (en)	1994-04-19
JPH08500357A (ja)	1996-01-16
EP0655056A1 (de)	1995-05-31
US5212185A (en)	1993-05-18
PT655056E (pt)	2000-04-28
WO1994004495A1 (en)	1994-03-03
GR3032526T3 (en)	2000-05-31
CA2136836C (en)	2004-08-03
AU3725393A (en)	1994-03-15
CA2136836A1 (en)	1994-03-03
DK0655056T3 (da)	2000-04-17
JP3363448B2 (ja)	2003-01-08
DE69327166T2 (de)	2000-04-20
DE69327166D1 (de)	2000-01-05

Legal Events

Date	Code	Title	Description
2000-04-15	UEP	Publication of translation of european patent specification
2006-11-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69023748D1 (de)	1996-01-04	Verwendung von Stickstoff enthaltenden Makrozyklen zur Behandlung retroviraler Infektionen.
DE69327166D1 (de)	2000-01-05	N-(dihydroxyalkyl)-ethinylalanin-amide mit endständiger azacyclyl-gruppe für die behandlung von bluthochdruck
NO20003133D0 (no)	2000-06-16	Anilidderivater, fremstilling og anvendelse derav
ATE233730T1 (de)	2003-03-15	Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende mittel und verfahren zu ihrer herstellung
CA2256582A1 (en)	1997-12-11	Oxa acids and related compounds for treating skin conditions
DE69613139D1 (de)	2001-07-05	Heterozyclische fungizide
NZ330868A (en)	2000-01-28	4-phenoxy, phenylthio or phenylamino substituted quinazoline derivatives ane medicaments useful as VEGF inhibitors
CA2263319A1 (en)	1998-04-02	Quinazoline derivatives and pharmaceutical compositions containing them
ES2107192T3 (es)	1997-11-16	Compuestos de alquilamino etinil alanina amino diol morfolino/tiomorfolino-terminados utiles como inhibidores de renina.
YU21100A (sh)	2002-11-15	Izohinolini kao urokinazni inhibitori
BG98124A (bg)	1994-11-15	Нови активни пирило-(2,3-бета) пиридин производни
ATE146460T1 (de)	1997-01-15	Alkylamino-ethynyl-alanin-aminodiolverbindungen mit imidazolyl/benzimidazolyl-endgruppe zur behandlung von bluthochdruck
GR3031861T3 (en)	2000-02-29	Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension.
IE42154L (en)	1976-02-20	Substituted phenyl ketones
ATE30714T1 (de)	1987-11-15	Neue aminoalkohole, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel und zwischenprodukte.
ATE177736T1 (de)	1999-04-15	Pyridinyl/quinolinyl-endgruppen enthaltende alkylamino-ethynyl-alanin-amindiol derivate zur behandlung von bluthochdruck
DK0431520T3 (da)	1995-04-10	Heterocycliske acylaminodiol-beta-aminosyrederivater
ATE144510T1 (de)	1996-11-15	N-(isochinolein-5-yl)-sulfonyl azazykloalkane, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
NO983527D0 (no)	1998-07-31	Dihydrobenzofuran og relaterte forbindelser anvendelig som anti-inflammatoriske midler
NO962809L (no)	1997-01-06	Fremgangsmåte for fremstilling av N-substituerte 4-ketoprolinderivater
ES2104416T3 (es)	1997-10-01	Glicosilamidas de 2-aminoacilamino-2-desoxi-azucares.
FI93457B (fi)	1994-12-30	Menetelmä metyleeni-pristinamysiini-IA- tai metyleeni-virginiamysiinijohdannaisten valmistamiseksi
DE3781691D1 (de)	1992-10-15	Tetrapeptid-hemmstoff zum eintritt in den kreislauf von hemopoietischen stammzellen, verfahren zu deren herstellung und deren anwendungen.
TH16651A (de)	1995-09-27